Minerva Neurosciences (NERV)
(Delayed Data from NSDQ)
$2.12 USD
0.00 (0.00%)
Updated Dec 24, 2024 12:46 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/27/2025
Time: -- |
12/2024 | $-1.05 | 0.00% |
Earnings Summary
For their last quarter, Minerva Neurosciences (NERV) reported earnings of $2.97 per share, beating the Zacks Consensus Estimate of $-1.01 per share. This reflects a positive earnings surprise of 394.06%. Look out for NERV's next earnings release expected on February 27, 2025. For the next earning release, we expect the company to report earnings of -$1.05 per share, reflecting a year-over-year increase of 11.76%.
Earnings History
Price & Consensus
Zacks News for NERV
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
NERV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Roche (RHHBY) Gets Positive CHMP Recommendation for Its Drugs
Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod
Bristol Myers' (BMY) Krazati Gets FDA Nod for Colorectal Cancer
NERV FAQs
Based on past history, Zacks believes Minerva Neurosciences, Inc (NERV) will report their next quarter earnings on February 27, 2025. For the next earning release, we expect the company to report earnings of -1.05 per share, reflecting a year-over-year increase of 11.76.
Based on past history, Zacks believes Minerva Neurosciences, Inc (NERV) will report their previous quarter earnings %%TIME_OF_DAY_CODE%% on February 27, 2025.
The Zacks Consensus Estimate for Minerva Neurosciences, Inc (NERV) for the quarter ending December 2024 is $-1.05 a share. We expect Minerva Neurosciences, Inc (NERV) to report earnings in line with the consensus estimate of $-1.05 per share
In the earnings report for the quarter ending in June 2024, Minerva Neurosciences, Inc (NERV) announced earnings of $-1.09 per share versus the Zacks Consensus Estimate of $-0.97 per share, representing a surprise of 12.37%.